Bailey John E. (Jack) Jr.
- SEC CIK
- 0001806147
No open-market purchases or sales filed in the past year.
Current role at each company
- GTHX G1 Therapeutics, Inc.President and CEOas of Sep 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bailey John E. (Jack) Jr. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Bailey John E. (Jack) Jr.President and CEO | SSale | −34.1K | $10.41 | −$355.2K | −12.8%233.2K after | |
| Jan 5, 2023 (view filing) | Jan 3-4 | 2 days | Bailey John E. (Jack) Jr.President and CEO | SSale | −37.6K | $5.81 | −$218.6K | −12.0%276.3K after | 2 lots |
| Jul 7, 2023 (view filing) | Jul 5 | 2 days | Bailey John E. (Jack) Jr.President and CEO | SSale | −2.72K | $2.45 | −$6.66K | −0.6%433.6K after | 10b5-1 |
| Jan 2, 2024 (view filing) | Jan 2 | Same day | Bailey John E. (Jack) Jr.President and CEO | SSale | −33.0K | $3.27 | −$107.9K | −7.6%400.6K after | |
| Jan 8, 2024 (view filing) | Jan 3 | 5 daysLate | Bailey John E. (Jack) Jr.President and CEO | SSale | −11.7K | $3.12 | −$36.5K | −2.3%489.6K after | 2 lots |
| May 15, 2024 (view filing) | May 13 | 2 days | Bailey John E. (Jack) Jr.President and CEO | SSale | −37.3K | $4.79 | −$178.5K | −7.6%452.3K after | |
| Jul 8, 2024 (view filing) | Jul 5 | 3 days | Bailey John E. (Jack) Jr.President and CEO | SSale | −7.66K | $2.51 | −$19.2K | −1.4%549.7K after |